Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 16/20 | 0.51 |
| ▸ | CHRM3 | P20309 | 14/20 | 0.51 |
| ▸ | CHRM1 | P11229 | 14/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | CA7 | P43166 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.45 |
| ▸ | LNPEP | Q9UIQ6 | 2/20 | 0.45 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5335986 | 0.89 | CHRM2 (0.44) | CHRM2CHRM3CHRM1 | |
| Trifluoroacetic Acid SCHEMBL5331362 | 0.87 | NAMPT (0.46) | CHRM2CHRM3CHRM1LNPEPERAP2 | |
| SCHEMBL5331370 | 0.76 | NAMPT (0.42) | CHRM2CHRM3CHRM1LNPEPERAP2 | |
| SCHEMBL5335982 | 0.71 | CHRM2 (0.52) | CHRM2CHRM3CHRM1 | |
| SCHEMBL4127725 | 0.71 | RAB9A (0.60) | CHRM2CHRM3CA12CA1CA2 | |
| SCHEMBL2903186 | 0.69 | BACE1 (0.58) | LNPEPERAP2 | |
| SCHEMBL24513853 | 0.68 | LNPEP (0.50) | CA12CA1CA2CA9LNPEP | |
| SCHEMBL29145378 | 0.68 | LNPEP (0.50) | CA12CA1CA2CA9LNPEP | |
| SCHEMBL4122707 | 0.68 | NPC1 (0.63) | CA12CA1CA2CA7CA9 | |
| SCHEMBL468900 | 0.68 | SLC7A5 (0.61) | LNPEPERAP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007018508-A1 | NOVEL M3 MUSCARINIC ACETYCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2007-02-15 | — | — | WO | disclosed |